Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy
Acta Pharmacologica Sinica2012Vol. 34(2), pp. 309–313
Citations Over TimeTop 10% of 2012 papers
Related Papers
- → The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatin(2001)86 cited
- → Antitumor effect of radioactive cisplatin (191Pt) on nude mice(2001)37 cited
- Modulation of cisplatin resistance by 2'-deoxy-5-azacytidine in human ovarian tumor cell lines.(1994)
- → Treatment with Paclitaxel Alone Rather than Combination with Paclitaxel and Cisplatin May be Selective for Cisplatin-resistant Ovarian Carcinoma(2000)10 cited
- The Relationship between Expression of 1-Cys Peroxiredoxin and Resistance to Cisplatin in Epithelial Ovarian Cancer Cell Lines.(2006)